These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38181273)

  • 1. The association between atherosclerosis and nonalcoholic fatty liver disease.
    Lv Q; Han Q; Wen Z; Pan Y; Chen J
    Medicine (Baltimore); 2024 Jan; 103(1):e36815. PubMed ID: 38181273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and heart failure.
    Li G; Lu Z; Chen Z
    Front Immunol; 2024; 15():1424308. PubMed ID: 39351239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of genes and key pathways underlying the pathophysiological association between nonalcoholic fatty liver disease and atrial fibrillation.
    Chu Y; Yu F; Wu Y; Yang J; Shi J; Ye T; Han D; Wang X
    BMC Med Genomics; 2022 Jul; 15(1):150. PubMed ID: 35790963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and atherosclerosis.
    Mo S; Wang Y; Yuan X; Wu W; Zhao H; Wei H; Qin H; Jiang H; Qin S
    Front Cardiovasc Med; 2023; 10():1142296. PubMed ID: 37063958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Bioinformatic Analysis of the Shared Molecular Mechanisms Between Osteoporosis and Atherosclerosis.
    Mo L; Ma C; Wang Z; Li J; He W; Niu W; Chen Z; Zhou C; Liu Y
    Front Endocrinol (Lausanne); 2022; 13():950030. PubMed ID: 35937806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of the core pathway of inflammatory bowel disease complicated with metabolic fatty liver and two-sample Mendelian randomization study of the causal relationships behind the disease.
    Wei Z; Wang J
    Front Immunol; 2024; 15():1375654. PubMed ID: 38698841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology.
    Yu C; Han D; Yu J; Zhu R; Zhu C; Wang F; Zhang T
    Medicine (Baltimore); 2023 Oct; 102(42):e35460. PubMed ID: 37861538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate genes investigation for severe nonalcoholic fatty liver disease based on bioinformatics analysis.
    Qi S; Wang C; Li C; Wang P; Liu M
    Medicine (Baltimore); 2017 Aug; 96(32):e7743. PubMed ID: 28796060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared Genes and Molecular Mechanisms between Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma Established by WGCNA Analysis.
    He J; Zhang X; Chen X; Xu Z; Chen X; Xu J
    Glob Med Genet; 2023 Sep; 10(3):144-158. PubMed ID: 37501756
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment.
    Sun CY; Yang LL; Zhao P; Yan PZ; Li J; Zhao DS
    Hereditas; 2022 Dec; 159(1):44. PubMed ID: 36451177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using bioinformatics and systems biology methods to identify the mechanism of interaction between COVID-19 and nonalcoholic fatty liver disease.
    Dong W; Jin Y; Shi H; Zhang X; Chen J; Jia H; Zhang Y
    Medicine (Baltimore); 2023 Jun; 102(23):e33912. PubMed ID: 37335656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LUM is the hub gene of advanced fibrosis in nonalcoholic fatty liver disease patients.
    Chang Y; He J; Xiang X; Li H
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101435. PubMed ID: 32386798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments.
    Wang J; Liu H; Xie G; Cai W; Xu J
    Mol Med Rep; 2020 Feb; 21(2):685-694. PubMed ID: 31974594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WGCNA-Based Identification of Hub Genes and Key Pathways Involved in Nonalcoholic Fatty Liver Disease.
    Zeng F; Shi M; Xiao H; Chi X
    Biomed Res Int; 2021; 2021():5633211. PubMed ID: 34938809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning.
    Cao Y; Du Y; Jia W; Ding J; Yuan J; Zhang H; Zhang X; Tao K; Yang Z
    Front Endocrinol (Lausanne); 2023; 14():1125829. PubMed ID: 36923221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
    Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
    PeerJ; 2022; 10():e14171. PubMed ID: 36389420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric Surgery.
    Zhang X; Li J; Liu T; Zhao M; Liang B; Chen H; Zhang Z
    Dis Markers; 2022; 2022():4369329. PubMed ID: 35789605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bioinformatics screening and analysis of key differentially expressed genes characteristics in nonalcoholic fatty liver disease].
    Ding JX; Huang WB; Jiang XX; Zhang LD; Fang H; Jin J
    Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):297-303. PubMed ID: 35462486
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioinformatics analysis of ferroptosis-related genes and immune cell infiltration in non-alcoholic fatty liver disease.
    Zhang H; Axinbai M; Zhao Y; Wei J; Qu T; Kong J; He Y; Zhang L
    Eur J Med Res; 2023 Dec; 28(1):605. PubMed ID: 38115130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.